Resource icon

Safety Study for NST-001 and the Neuroject Injection Set to Treat Tinnitus

This research study involves an experimental drug (NST_001) and a delivery system. The main purpose of this research study is to investigate the safety of NST-001, delivered directly to the inner ear for the treatment of tinnitus.


Estimated Enrollment: 24
Study Start Date: January 2009
Estimated Study Completion Date: December 2011
Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Author
Tinnitus Talk
Views
36
First release
Last update
Rating
0.00 star(s) 0 ratings

More resources from Tinnitus Talk